252 related articles for article (PubMed ID: 33891332)
1. Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease.
Caputo M; Kurhe Y; Kumari S; Cansby E; Amrutkar M; Scandalis E; Booten SL; Ståhlman M; Borén J; Marschall HU; Aghajan M; Mahlapuu M
FASEB J; 2021 May; 35(5):e21567. PubMed ID: 33891332
[TBL] [Abstract][Full Text] [Related]
2. Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease.
Cansby E; Nuñez-Durán E; Magnusson E; Amrutkar M; Booten SL; Kulkarni NM; Svensson LT; Borén J; Marschall HU; Aghajan M; Mahlapuu M
Cell Mol Gastroenterol Hepatol; 2019; 7(3):597-618. PubMed ID: 30576769
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase MST3 modulates lipid homeostasis in hepatocytes and correlates with nonalcoholic steatohepatitis in humans.
Cansby E; Kulkarni NM; Magnusson E; Kurhe Y; Amrutkar M; Nerstedt A; Ståhlman M; Sihlbom C; Marschall HU; Borén J; Blüher M; Mahlapuu M
FASEB J; 2019 Sep; 33(9):9974-9989. PubMed ID: 31173506
[TBL] [Abstract][Full Text] [Related]
4. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
Kim S; Hong J; Jeon R; Kim HS
Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
[TBL] [Abstract][Full Text] [Related]
5. Silencing of STE20-type kinase TAOK1 confers protection against hepatocellular lipotoxicity through metabolic rewiring.
Xia Y; Andersson E; Anand SK; Cansby E; Caputo M; Kumari S; Porosk R; Kilk K; Nair S; Marschall HU; Blüher M; Mahlapuu M
Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36930872
[TBL] [Abstract][Full Text] [Related]
6. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
Hong Y; Choi SI; Hong E; Kim GH
J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
[TBL] [Abstract][Full Text] [Related]
7. Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (
Wu M; Lo TH; Li L; Sun J; Deng C; Chan KY; Li X; Yeh ST; Lee JTH; Lui PPY; Xu A; Wong CM
Elife; 2023 Aug; 12():. PubMed ID: 37580962
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate.
Rajamoorthi A; Arias N; Basta J; Lee RG; Baldán Á
J Lipid Res; 2017 Nov; 58(11):2127-2138. PubMed ID: 28874443
[TBL] [Abstract][Full Text] [Related]
9. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
10. Chokeberry attenuates the expression of genes related to de novo lipogenesis in the hepatocytes of mice with nonalcoholic fatty liver disease.
Park H; Liu Y; Kim HS; Shin JH
Nutr Res; 2016 Jan; 36(1):57-64. PubMed ID: 26773781
[TBL] [Abstract][Full Text] [Related]
11. Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice.
Xia Y; Andersson E; Caputo M; Cansby E; Sedda F; Font-Gironès F; Ruud J; Kurhe Y; Hallberg B; Marschall HU; Asterholm IW; Romeo S; Blüher M; Mahlapuu M
Mol Med; 2023 Oct; 29(1):138. PubMed ID: 37864157
[TBL] [Abstract][Full Text] [Related]
12. Peroxiredoxin 5 ameliorates obesity-induced non-alcoholic fatty liver disease through the regulation of oxidative stress and AMP-activated protein kinase signaling.
Kim MH; Seong JB; Huh JW; Bae YC; Lee HS; Lee DS
Redox Biol; 2020 Jan; 28():101315. PubMed ID: 31505325
[TBL] [Abstract][Full Text] [Related]
13. Hepatic LKB1 Reduces the Progression of Non-Alcoholic Fatty Liver Disease via Genomic Androgen Receptor Signaling.
Heo JH; Lee SR; Jo SL; Ko JW; Kwon HJ; Hong EJ
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360667
[TBL] [Abstract][Full Text] [Related]
14. Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice.
Nuñez-Durán E; Aghajan M; Amrutkar M; Sütt S; Cansby E; Booten SL; Watt A; Ståhlman M; Stefan N; Häring HU; Staiger H; Borén J; Marschall HU; Mahlapuu M
Hepatol Commun; 2018 Jan; 2(1):69-83. PubMed ID: 29404514
[TBL] [Abstract][Full Text] [Related]
15. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
[TBL] [Abstract][Full Text] [Related]
16. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
17. Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway.
Jung TW; Kim HC; Abd El-Aty AM; Jeong JH
J Biol Chem; 2018 Mar; 293(11):3981-3988. PubMed ID: 29414781
[TBL] [Abstract][Full Text] [Related]
18. GCKIII kinases in lipotoxicity: Roles in NAFLD and beyond.
Mahlapuu M; Caputo M; Xia Y; Cansby E
Hepatol Commun; 2022 Oct; 6(10):2613-2622. PubMed ID: 35641240
[TBL] [Abstract][Full Text] [Related]
19. STE20-type kinases MST3 and MST4 promote the progression of hepatocellular carcinoma: Evidence from human cell culture and expression profiling of liver biopsies.
Caputo M; Xia Y; Anand SK; Cansby E; Andersson E; Marschall HU; Königsrainer A; Peter A; Mahlapuu M
FASEB J; 2023 Aug; 37(8):e23105. PubMed ID: 37490000
[TBL] [Abstract][Full Text] [Related]
20. GCN2 deficiency protects against high fat diet induced hepatic steatosis and insulin resistance in mice.
Liu S; Yuan J; Yue W; Bi Y; Shen X; Gao J; Xu X; Lu Z
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3257-3267. PubMed ID: 30006154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]